Ligand validation:5QD8

E6V: (3S,14R,16S)-16-[(1R)-2-{[(4S)-2,2-dimethyl-6-(propan-2-yl)-3,4-dihydro-2H-1-benzopyran-4-yl]amino}-1-hydroxyethyl]-3,4,14-trimethyl-1,4-diazacyclohexadecane-2,5-dione

E6V is a Ligand Of Interest in 5QD8 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5QD8_E6V_C_401	61%	71%	0.173	0.962	0.66	0.47	1	-	0	0	100%	1
5QD8_E6V_A_401	54%	69%	0.194	0.959	0.68	0.53	-	-	1	0	100%	0.9875
5QD8_E6V_B_401	52%	67%	0.195	0.955	0.63	0.65	-	1	0	0	100%	0.9625

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.